Wezlana Chronology: From Biosimilar To Interchangeable In The Blink Of An Eye
Executive Summary
Pink Sheet’s Drug Review Profile looks at the timeline behind the development and FDA review of Amgen’s Wezlana (ustekinumab-auub), an interchangeable biosimilar to Janssen’s Stelara.